(Allergan plc)

	AGN latest price $195.0596 (-2.64%) ($194.5963 - $202.4142) on Mon. Nov. 14, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.13% (three month average)
RSI	37
Latest Price	$195.0596(-2.64%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.3% a day on average for past five trading days.
Weekly Trend	AGN declines -2.3% a week on average for past two weeks.
Market Behavior	Rotation from growth to value for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(51%)    XLV(50%)    XBI(45%)    ARKG(43%)    IVE(42%)
Factors Impacting AGN price	AGN will decline at least -1.065% in a week (0% probabilities).   VIXM(-29%)    TLT(-17%)    UUP(-13%)    SHY(-3%)    IGOV(-2%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.065% (StdDev 2.13%)
Hourly BBV	0 ()
Intraday Trend	-3.4%

Resistance Level	$205.07
5 Day Moving Average	$199.74(-2.34%)
10 Day Moving Average	$195.61(-0.28%)
20 Day Moving Average	$205.07(-4.88%)
To recent high	-20.4%
To recent low	7%
Market Cap	$64.311b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed